FTC sues key pharmacy gain supervisors about insulin selling prices The company introduced action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list cost of everyday living-conserving insulin medicine. Wherever are all of the nurses? Hospitals, advocates disagree on crisis Hospitals https://trentonqojhb.wssblogs.com/30675915/rumored-buzz-on-healthcare-news